Sanofi looks to join M&A trend

Sanofi's Interim CEO Serge Weinberg says the drug company wants to “have businesses like consumer healthcare, veterinary medicine and vaccines that are less strongly driven by innovation but grow continuously and are more stable,” reports Reuters, which found the item in the German paper Handelsblatt.

Weinberg also said the company would not follow through with former CEO Chris Viehbarcher's plan to try to offload some of the company's older drugs because “we do not think that would be a good idea.”

The interim chief executive said the company is ready to buy up businesses that meet the stable growth criteria, but would not name names, other than to say the French company was not interested in picking up Bayer's diabetes business.